340B Matters | News
15484
page-template,page-template-blog-large-image,page-template-blog-large-image-php,page,page-id-15484,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-9.1.3,wpb-js-composer js-comp-ver-4.11.1,vc_responsive

10 Jul 340B may curb high drug prices, new JAMA study finds

The 340B drug pricing program may discourage drug manufacturers from raising prices and instead may have the effect of reducing list prices for certain drugs. That’s according to a new study published in the Journal of the American Medical Association (JAMA). Study authors Sean Dickson of West Health and Ian...

Read More

30 Apr 340B Informed: 340B Hospitals Are in the Trenches of the Measles Battle

"As the worst measles outbreak in decades continues, public health officials’ attention has focused on the importance of vaccinations to avoid spreading the disease. Hospitals participating in 340B are among those responding to the outbreak. One such 340B hospital is Montefiore Nyack Hospital, a 375-bed acute...

Read More

26 Mar Red State: Trump Allies Going Against Discount Drug Campaign Promises

"Healthcare reform takes many forms, and some are better known than others. One that can sometimes slip under-the-radar is the 340b program, which requires drug companies to provide medications at a reduced rate to certain organizations including rural referral centers, hospitals providing indigent care, and...

Read More